Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.59% | $4.41M | €343.40B | 30.68% | 76 Outperform | |
| ― | 1.27% | $3.51M | ― | ― | ― | |
| Roche Holding AG | 1.20% | $3.32M | CHF263.28B | 52.00% | 73 Outperform | |
| AstraZeneca | 1.18% | $3.27M | £211.99B | 31.03% | 80 Outperform | |
| HSBC Holdings | 1.10% | $3.04M | HK$2.12T | 52.25% | 80 Outperform | |
| SAP SE | 1.07% | $2.96M | €242.41B | -12.02% | 66 Neutral | |
| Nestlé SA | 1.05% | $2.92M | CHF196.70B | 19.48% | 71 Outperform | |
| Novartis AG | 1.05% | $2.91M | CHF209.54B | 25.57% | 80 Outperform | |
| Royal Bank Of Canada | 0.99% | $2.75M | $239.43B | 41.39% | 75 Outperform | |
| Siemens | 0.93% | $2.57M | €186.24B | 25.18% | 74 Outperform |